港股異動丨平安好醫生漲3.24% 股價再創歷史新高
格隆匯4月16日丨平安好醫生(1833.HK)漲3.24%,報97.3港元再創歷史新高,近18個交易日累計漲幅達63%,總市值1038億港元。

據格隆匯APP數據顯示,過去兩日持續有南下資金淨買入平安好醫生,合共4億港元淨買入。

此外,大和最新發表研究報告指出,平安好醫生打通湖北省醫保支付,在納入湖北省國家藥物報銷目錄獲得顯著進展,為其帶來突破,加上政策的推動為平安好醫生開展增長潛力,該行重申其“跑贏大市”投資評級,目標價由85港元上調11.76%至95港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.